REKIA HILL: Open Payments
NPI 1053182527 · WORTHINGTON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$781 in 26 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $556 · 2025 $781
Food & beverage: $781
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 2 | $230 |
| Otsuka America Pharmaceutical, Inc. | 3 | $145 |
| Vanda Pharmaceuticals Inc. | 4 | $86 |
| Alkermes, Inc. | 3 | $55 |
| Tris Pharma Inc | 3 | $52 |
| ABBVIE INC. | 3 | $50 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $45 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $25 |
| Neurocrine BioSciences, Inc. | 1 | $23 |
| Supernus Pharmaceuticals, Inc. | 1 | $22 |
Products named: Auvelity, REXULTI, Dyanavel XR, FANAPT, VRAYLAR, CAPLYTA, HETLIOZ, ARISTADA.
Industry payments across OH — which companies pay providers there.
